Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of dermatomyositis and polymyositis with anti-tumor necrosis factor-alpha: long-term follow-up.

× No keyword cloud information.

22 in total

Review 1. Treatment of inflammatory myopathy: emerging therapies and therapeutic targets.

Authors: Siamak Moghadam-Kia; Rohit Aggarwal; Chester V Oddis
Journal: Expert Rev Clin Immunol Date: 2015-08-27 Impact factor: 4.473

Review 2. Skeletal muscle disorders associated with inflammatory bowel diseases: occurrence of myositis in a patient with ulcerative colitis and Hashimoto's thyroiditis--case report and review of the literature.

Authors: Omero Alessandro Paoluzi; Pietro Crispino; Margherita Rivera; Federico Iacopini; Dino Palladini; Adriana Consolazio; Paolo Paoluzi
Journal: Int J Colorectal Dis Date: 2005-10-05 Impact factor: 2.571

Review 3. [Current treatments of dermatomyositis and polymyositis].

Authors: J Richter; C Iking-Konert
Journal: Z Rheumatol Date: 2007-12 Impact factor: 1.372

Review 4. Immunotherapy of myositis: issues, concerns and future prospects.

Authors: Marinos C Dalakas
Journal: Nat Rev Rheumatol Date: 2010-02-02 Impact factor: 20.543

5. A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositis.

Authors: Adam Schiffenbauer; Megha Garg; Christine Castro; Angelina Pokrovnichka; Galen Joe; Joseph Shrader; Imelda Victoria Cabalar; Sara Faghihi-Kashani; Michael O Harris-Love; Paul H Plotz; Frederick W Miller; Mark Gourley
Journal: Semin Arthritis Rheum Date: 2017-10-16 Impact factor: 5.532

Review 6. Treatment in myositis.

Authors: Chester V Oddis; Rohit Aggarwal
Journal: Nat Rev Rheumatol Date: 2018-03-29 Impact factor: 20.543

7. Contribution of tumour necrosis factor alpha and interleukin (IL) 1beta to IL6 production, NF-kappaB nuclear translocation, and class I MHC expression in muscle cells: in vitro regulation with specific cytokine inhibitors.

Authors: G Chevrel; C Granet; P Miossec
Journal: Ann Rheum Dis Date: 2005-02-24 Impact factor: 19.103

Treatment of dermatomyositis and polymyositis with anti-tumor necrosis factor-alpha: long-term follow-up.